Robert J. Hickey

4.2k total citations
103 papers, 3.3k citations indexed

About

Robert J. Hickey is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Robert J. Hickey has authored 103 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 33 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Robert J. Hickey's work include DNA Repair Mechanisms (40 papers), Cancer therapeutics and mechanisms (16 papers) and Neuroblastoma Research and Treatments (16 papers). Robert J. Hickey is often cited by papers focused on DNA Repair Mechanisms (40 papers), Cancer therapeutics and mechanisms (16 papers) and Neuroblastoma Research and Treatments (16 papers). Robert J. Hickey collaborates with scholars based in United States, Germany and Finland. Robert J. Hickey's co-authors include Linda H. Malkas, Lacey E. Dobrolecki, Miloš V. Novotný, Yehia Mechref, Lauren A. Schnaper, Yves Pommier, Melanie Smith, André A. Pilon, Dirk Strumberg and John A. Sandoval and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Robert J. Hickey

95 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Hickey United States 31 2.7k 854 388 294 292 103 3.3k
Linda H. Malkas United States 29 2.3k 0.8× 866 1.0× 368 0.9× 178 0.6× 148 0.5× 95 2.8k
Kohji Noguchi Japan 29 2.0k 0.7× 1.0k 1.2× 272 0.7× 137 0.5× 242 0.8× 108 3.3k
Thomas O’Brien United States 31 2.7k 1.0× 743 0.9× 337 0.9× 364 1.2× 82 0.3× 62 3.6k
Monica Schenone United States 17 2.7k 1.0× 604 0.7× 399 1.0× 254 0.9× 165 0.6× 33 3.5k
Moulay A. Alaoui‐Jamali Canada 42 3.1k 1.2× 1.3k 1.5× 792 2.0× 332 1.1× 93 0.3× 138 4.8k
A. Chaikuad Germany 37 2.9k 1.1× 784 0.9× 231 0.6× 760 2.6× 104 0.4× 123 4.4k
Pascal Gauduchon France 37 1.7k 0.6× 642 0.8× 999 2.6× 171 0.6× 120 0.4× 107 3.2k
Ajit Bharti United States 35 3.2k 1.2× 957 1.1× 343 0.9× 175 0.6× 77 0.3× 55 4.3k
H. Grunicke Austria 34 2.3k 0.8× 829 1.0× 325 0.8× 217 0.7× 70 0.2× 123 3.3k
V. Kinzel Germany 31 2.6k 1.0× 433 0.5× 260 0.7× 188 0.6× 180 0.6× 126 3.5k

Countries citing papers authored by Robert J. Hickey

Since Specialization
Citations

This map shows the geographic impact of Robert J. Hickey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Hickey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Hickey more than expected).

Fields of papers citing papers by Robert J. Hickey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Hickey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Hickey. The network helps show where Robert J. Hickey may publish in the future.

Co-authorship network of co-authors of Robert J. Hickey

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Hickey. A scholar is included among the top collaborators of Robert J. Hickey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Hickey. Robert J. Hickey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lingeman, Robert, Min Li, Toni T. Seppälä, et al.. (2025). Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma. Gastroenterology. 169(4). 600–614.e11.
2.
Lingeman, Robert, Robert J. Hickey, & Linda H. Malkas. (2024). Abstract 1875: Enhanced lung cancer treatment using AOH1996, a potent PCNA inhibitor. Cancer Research. 84(6_Supplement). 1875–1875.
3.
Gu, Long, Robert J. Hickey, & Linda H. Malkas. (2023). Therapeutic Targeting of DNA Replication Stress in Cancer. Genes. 14(7). 1346–1346. 15 indexed citations
4.
Lingeman, Robert, et al.. (2020). Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide. Molecular Therapy — Oncolytics. 17. 250–256. 23 indexed citations
5.
Gu, Long, Robert Lingeman, Emily Sun, et al.. (2018). The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Clinical Cancer Research. 24(23). 6053–6065. 33 indexed citations
6.
Wang, Xiaoyan, Robert J. Hickey, Linda H. Malkas, et al.. (2010). Elevated expression of cancer‐associated proliferating cell nuclear antigen in high‐grade prostatic intraepithelial neoplasia and prostate cancer. The Prostate. 71(7). 748–754. 24 indexed citations
7.
Mann, Benjamin F., Milan Maděra, Iveta Kloučková, et al.. (2010). A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinoma. Electrophoresis. 31(11). 1833–1841. 27 indexed citations
8.
Zhong, Xiaoling, et al.. (2008). Applications of emerging molecular technologies in glioblastoma multiforme. Expert Review of Neurotherapeutics. 8(10). 1497–1506. 22 indexed citations
9.
Novotny, Nathan M., Jay L. Grosfeld, Frederick J. Rescorla, et al.. (2008). Oxidative status in neuroblastoma: a source of stress?. Journal of Pediatric Surgery. 43(2). 330–334. 9 indexed citations
10.
Sandoval, John A., et al.. (2006). Neuroblastoma 3D cell culture: Proteomic differences between cancer spheroids and monolayers. Cancer Research. 66. 1019–1020. 1 indexed citations
11.
Escobar, Mauricio A., Derek J. Hoelz, John A. Sandoval, et al.. (2005). Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints. Journal of Pediatric Surgery. 40(2). 349–358. 11 indexed citations
12.
Strumberg, Dirk, André A. Pilon, Melanie Smith, et al.. (2000). Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff. Molecular and Cellular Biology. 20(11). 3977–3987. 292 indexed citations
13.
Jiang, Haiyan, et al.. (2000). Ara-C affects formation of cancer cell DNA synthesome replication intermediates. Cancer Chemotherapy and Pharmacology. 45(4). 312–319. 24 indexed citations
15.
Coll, Jennifer M., Robert J. Hickey, Lauren A. Schnaper, et al.. (1997). Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.. PubMed. 9(11-12). 629–39. 15 indexed citations
16.
Hickey, Robert J., et al.. (1997). The biochemical status of the DNA synthesome can distinguish between permanent and temporary cell growth arrest.. PubMed. 8(12). 1359–69. 11 indexed citations
17.
Hickey, Robert J. & Linda H. Malkas. (1997). Mammalian Cell DNA Replication. Critical Reviews in Eukaryotic Gene Expression. 7(1-2). 125–157. 28 indexed citations
18.
Bachur, N R, Fang Yu, R Johnson, et al.. (1992). Helicase inhibition by anthracycline anticancer agents.. Molecular Pharmacology. 41(6). 993–998. 81 indexed citations
19.
Malkas, Linda H., Robert J. Hickey, Congjun Li, Nina Marie Pedersen, & Earl F. Baril. (1990). A 21S enzyme complex from HeLa cells that functions in simian virus 40 DNA replication in vitro. Biochemistry. 29(27). 6362–6374. 89 indexed citations
20.
Hickey, Robert J., Arthur I. Skoultchi, Peter W. Gunning, & Larry Kedes. (1986). Regulation of a Human Cardiac Actin Gene Introduced Into Rat L6 Myoblasts Suggests a Defect in Their Myogenic Program. Molecular and Cellular Biology. 6(9). 3287–3290. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026